Cargando…
Improving Hepatitis B Vaccine Efficacy in End-Stage Renal Diseases Patients and Role of Adjuvants
Hepatitis B virus (HBV) infection is a serious global health problem.The prevalence of viral hepatitis is higher in dialysis patients than in the general population because of the opportunity for exposure during the dialysis procedure. Immunization is the most effective way to prevent transmission o...
Autores principales: | Somi, Mohammad Hossein, Hajipour, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458294/ https://www.ncbi.nlm.nih.gov/pubmed/23029621 http://dx.doi.org/10.5402/2012/960413 |
Ejemplares similares
-
Safety and efficacy of vemurafenib in end stage renal failure
por: Iddawela, Mahesh, et al.
Publicado: (2013) -
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
por: Pleyer, Christopher, et al.
Publicado: (2021) -
COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients
por: Moreno, Nicolas F., et al.
Publicado: (2022) -
Evaluation of adjuvant effects of fucoidan for improving vaccine efficacy
por: Kim, Su-Yeon, et al.
Publicado: (2015) -
1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)